You are here: Home >>About Us >>Team introduction
Team introduction
Xiaoli Chai, Vice General Manager

Ms Chai started her career in pharmaceutical R&D in 2008. Over the past decade, she has served as the quality manager of xuanzhu pharma and KBP Biosciences, deeply involved in the development of more than 10 innovative drugs in class 1.1 from early drug candidates to clinical trials. One of the drugs obtained US FDA Qualified Infectious Disease Product (QIDP) and Fast Track Designations. During this period, she was also promoted to the company management team and fully participated in the operation and management of the company. Later, she joined United-Power Pharma and served as the director of operations, responsible for the establishment of the project management team and the establishment and operation management of the Shanghai branch.
“I am honored  to join fontacea and serves as the team leader to  develop and commercialize the  Johnson & Johnson’s CNTO6785  in the People's Republic of China including the Hong Kong SAR, the Macao SAR, the Taiwan region and the republic of Korea.
Jinan is my second hometown. fontacea provides me with the opportunity and platform to work here again.”

Liang Li, Ph.D., VP of R&D
 
Dr. Li’s role combines the leadership of corporate R&D strategy, management of the project team, and collaborations with the academic and medical community.  During his research work in Oncology, Immunology, NASH, Diabetes and stem cell biology, Dr. Li focussed on Drug Target Discovery, Mechanism of Action and the technical and commercial evaluation of drug candidates. He identified several potential drug targets in the TNBC that are resistant to IGF1R inhibitors treatment. He elucidated the interaction of the anti-tropomyosin compound with the Tpm3.1/actin co-polymer. He also contributed to the literature of Wnt/β-catenin signaling. Before joining Fontacea, Dr. Li worked at Guangzhou Boji Medical Biotechnological co., Ltd.
Dr. Li was a Postdoctoral Fellow at University of New South Wales after earned his PhD of Biochemistry from University of Adelaide.
After years of study and work abroad, I want to go back to my local community to contribute my knowledge. Fontacea provides me a great opportunity to work closely with the scientists and medics in the city I graduated from, many of whom are my friends, to benefits the patients and raise the profile of Jinan in the pharmaceutical industry.     

Junlian Wang, Project manger

Extensive experience in clinical trial projects management. These drugs includes involve anti-tumor drugs, digestion and anti-infection drugs, many of these drugs are in the class of 1.1 drugs in China. He worked in CTTQ and LUYE PHARMA GROUP before joined Fontacea.
“The excellent team and innovative spirit of FONTACEA attracted me, and I would like to contribute my efforts“

Haoyang Li, Quality Manager

Years of experience in biomedical quality management. He specializes in the processes of aseptic drug manufacturing, cell fermentation culture, protein purification, and conjugation drugs. He implements the GMP quality system in his routine work. Mr Li worked in RemeGen, Ltd. and CDMO before joined Fontacea.
“I joined Fontacea to promote the industrialization of more new biological drugs, and establish an international level of drug production management system to benefit more patients, which is in line with the goal of Fontaca.”